Papillary thyroid cancer—Aggressive variants and impact on management: A narrative review
A Coca-Pelaz, JP Shah, JC Hernandez-Prera… - Advances in …, 2020 - Springer
Introduction Aggressive variants of papillary thyroid cancer (PTC) have been described with
increasing frequency. These variants include diffuse sclerosing variant, tall cell variant …
increasing frequency. These variants include diffuse sclerosing variant, tall cell variant …
[HTML][HTML] Updates in the pathologic classification of thyroid neoplasms: a review of the World Health Organization classification
Advances in medical sciences and evidence-based medicine have led to momentous
changes in classification and management of thyroid neoplasms. Much progress has been …
changes in classification and management of thyroid neoplasms. Much progress has been …
[HTML][HTML] Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular …
Thyroid tumors formerly classified as non-invasive encapsulated follicular variant of papillary
thyroid carcinoma were recently renamed 'non-invasive follicular thyroid neoplasm with …
thyroid carcinoma were recently renamed 'non-invasive follicular thyroid neoplasm with …
[HTML][HTML] Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology
X Wang, W Cheng, C Liu, J Li - Oncotarget, 2016 - ncbi.nlm.nih.gov
Tall cell variant (TCV) of papillary thyroid carcinoma (PTC) has been recognized for the past
few decades as an entity showing aggressive biological behavior; however, there is …
few decades as an entity showing aggressive biological behavior; however, there is …
Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification
This review addresses the impact of molecular alterations on the diagnosis and prognosis of
differentiated thyroid carcinoma (DTC), including papillary, follicular, and well-differentiated …
differentiated thyroid carcinoma (DTC), including papillary, follicular, and well-differentiated …
Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation
Background Mutations in the TERT promoter, ALK rearrangement, and the BRAF V600E
mutation are associated with aggressive clinicopathologic features in thyroid cancers …
mutation are associated with aggressive clinicopathologic features in thyroid cancers …
The Impact of BRAF V600E Mutation Allele Frequency on the Histopathological Characteristics of Thyroid Cancer
M Abdulhaleem, S Bandargal, MP Pusztaszeri… - Cancers, 2023 - mdpi.com
Simple Summary This study aimed to investigate the relationship between the allele
frequency (AF) of the BRAF V600E mutation and the histopathological features of papillary …
frequency (AF) of the BRAF V600E mutation and the histopathological features of papillary …
Tall cell variant of papillary thyroid carcinoma: impact of change in WHO definition and molecular analysis
KS Wong, SE Higgins, E Marqusee, MA Nehs… - Endocrine …, 2019 - Springer
The morphologic criteria for tall cell variant (TCV) of papillary thyroid carcinoma (PTC) were
modified in the 2017 WHO Classification of Tumors of Endocrine Organs, with a decrease in …
modified in the 2017 WHO Classification of Tumors of Endocrine Organs, with a decrease in …
[HTML][HTML] Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature …
The hobnail variant of papillary thyroid carcinoma (PTC) is a rare, aggressive variant in
which> 30% of the tumor cells have hobnail features. The clinical behavior and pathologic …
which> 30% of the tumor cells have hobnail features. The clinical behavior and pathologic …
Update on the cytologic features of papillary thyroid carcinoma variants
M Pusztaszeri, M Auger - Diagnostic cytopathology, 2017 - Wiley Online Library
Papillary thyroid cancer (PTC), which accounts for 85–90% of all thyroid cancers, is
generally an indolent tumor with long term survival rates> 95%. A reliable definitive …
generally an indolent tumor with long term survival rates> 95%. A reliable definitive …